| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |